MA55319A - Procédé de transcription in vitro à alimentation semi-discontinue - Google Patents
Procédé de transcription in vitro à alimentation semi-discontinueInfo
- Publication number
- MA55319A MA55319A MA055319A MA55319A MA55319A MA 55319 A MA55319 A MA 55319A MA 055319 A MA055319 A MA 055319A MA 55319 A MA55319 A MA 55319A MA 55319 A MA55319 A MA 55319A
- Authority
- MA
- Morocco
- Prior art keywords
- semi
- vitro transcription
- transcription method
- discontinue feeding
- discontinue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q3/00—Condition responsive control processes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962816734P | 2019-03-11 | 2019-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA55319A true MA55319A (fr) | 2022-01-19 |
Family
ID=72426291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA055319A MA55319A (fr) | 2019-03-11 | 2020-03-11 | Procédé de transcription in vitro à alimentation semi-discontinue |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220145381A1 (fr) |
EP (1) | EP3938507A4 (fr) |
JP (1) | JP2022526089A (fr) |
KR (1) | KR20210149727A (fr) |
CN (1) | CN113874502A (fr) |
AU (1) | AU2020239037A1 (fr) |
CA (1) | CA3132975A1 (fr) |
MA (1) | MA55319A (fr) |
MX (1) | MX2021011031A (fr) |
WO (1) | WO2020185811A1 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11364292B2 (en) | 2015-07-21 | 2022-06-21 | Modernatx, Inc. | CHIKV RNA vaccines |
WO2017031232A1 (fr) | 2015-08-17 | 2017-02-23 | Modernatx, Inc. | Procédés de préparation de particules et compositions associées |
SI3718565T1 (sl) | 2015-10-22 | 2022-08-31 | Modernatx, Inc. | Cepiva za respiratorni virus |
EA201891001A1 (ru) | 2015-10-22 | 2018-11-30 | МОДЕРНАТиЭкс, ИНК. | Вакцины на основе нуклеиновых кислот против вируса ветряной оспы (vzv) |
EP3364950A4 (fr) | 2015-10-22 | 2019-10-23 | ModernaTX, Inc. | Vaccins contre des maladies tropicales |
AU2016342045A1 (en) | 2015-10-22 | 2018-06-07 | Modernatx, Inc. | Human cytomegalovirus vaccine |
WO2017099823A1 (fr) | 2015-12-10 | 2017-06-15 | Modernatx, Inc. | Compositions et procédés permettant d'administrer des agents thérapeutiques |
MX2019002904A (es) | 2016-09-14 | 2019-09-26 | Modernatx Inc | Composiciones de arn de alta pureza y métodos para su preparación. |
JP6980780B2 (ja) | 2016-10-21 | 2021-12-15 | モデルナティーエックス, インコーポレイテッド | ヒトサイトメガロウイルスワクチン |
EP3538146A4 (fr) | 2016-11-11 | 2020-07-15 | ModernaTX, Inc. | Vaccin antigrippal |
EP3551193A4 (fr) | 2016-12-08 | 2020-08-19 | Modernatx, Inc. | Vaccins à acide nucléique contre des virus respiratoires |
US11384352B2 (en) | 2016-12-13 | 2022-07-12 | Modernatx, Inc. | RNA affinity purification |
MA52262A (fr) | 2017-03-15 | 2020-02-19 | Modernatx Inc | Vaccin à large spectre contre le virus de la grippe |
US11752206B2 (en) | 2017-03-15 | 2023-09-12 | Modernatx, Inc. | Herpes simplex virus vaccine |
WO2018170270A1 (fr) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Vaccin contre le virus varicelle-zona |
EP3595713A4 (fr) | 2017-03-15 | 2021-01-13 | ModernaTX, Inc. | Vaccin contre le virus respiratoire syncytial |
US20200030432A1 (en) | 2017-03-17 | 2020-01-30 | Modernatx, Inc. | Zoonotic disease rna vaccines |
EP3607074A4 (fr) | 2017-04-05 | 2021-07-07 | Modernatx, Inc. | Réduction ou élimination de réponses immunitaires à des protéines thérapeutiques administrées par voie non intraveineuse, par exemple par voie sous-cutanée |
US11786607B2 (en) | 2017-06-15 | 2023-10-17 | Modernatx, Inc. | RNA formulations |
US11866696B2 (en) | 2017-08-18 | 2024-01-09 | Modernatx, Inc. | Analytical HPLC methods |
WO2019036685A1 (fr) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | Procédés pour analyse par clhp |
CN111212905A (zh) | 2017-08-18 | 2020-05-29 | 摩登纳特斯有限公司 | Rna聚合酶变体 |
WO2019046809A1 (fr) | 2017-08-31 | 2019-03-07 | Modernatx, Inc. | Procédés de fabrication de nanoparticules lipidiques |
MA50253A (fr) | 2017-09-14 | 2020-07-22 | Modernatx Inc | Vaccins à arn contre le virus zika |
WO2019148101A1 (fr) | 2018-01-29 | 2019-08-01 | Modernatx, Inc. | Vaccins à base d'arn contre le vrs |
US11851694B1 (en) | 2019-02-20 | 2023-12-26 | Modernatx, Inc. | High fidelity in vitro transcription |
CN113795579A (zh) * | 2019-02-20 | 2021-12-14 | 摩登纳特斯有限公司 | 用于共转录加帽的rna聚合酶变体 |
CN113521268A (zh) | 2020-04-22 | 2021-10-22 | 生物技术Rna制药有限公司 | 冠状病毒疫苗 |
US11406703B2 (en) | 2020-08-25 | 2022-08-09 | Modernatx, Inc. | Human cytomegalovirus vaccine |
WO2023069900A1 (fr) * | 2021-10-18 | 2023-04-27 | Modernatx, Inc. | Souche bactérienne personnalisée pour production de protéines recombinantes |
CN115260264B (zh) * | 2022-02-28 | 2023-06-09 | 广州市恒诺康医药科技有限公司 | 用于rna加帽的化合物及其应用 |
US11878055B1 (en) | 2022-06-26 | 2024-01-23 | BioNTech SE | Coronavirus vaccine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT3155129T (pt) * | 2014-06-10 | 2019-05-16 | Curevac Ag | Método para potenciar a produção de arn |
MX2019002904A (es) * | 2016-09-14 | 2019-09-26 | Modernatx Inc | Composiciones de arn de alta pureza y métodos para su preparación. |
CN111212905A (zh) * | 2017-08-18 | 2020-05-29 | 摩登纳特斯有限公司 | Rna聚合酶变体 |
-
2020
- 2020-03-11 WO PCT/US2020/021955 patent/WO2020185811A1/fr unknown
- 2020-03-11 AU AU2020239037A patent/AU2020239037A1/en not_active Abandoned
- 2020-03-11 EP EP20770886.8A patent/EP3938507A4/fr active Pending
- 2020-03-11 KR KR1020217032102A patent/KR20210149727A/ko unknown
- 2020-03-11 CA CA3132975A patent/CA3132975A1/fr active Pending
- 2020-03-11 US US17/438,049 patent/US20220145381A1/en active Pending
- 2020-03-11 MX MX2021011031A patent/MX2021011031A/es unknown
- 2020-03-11 CN CN202080034511.9A patent/CN113874502A/zh active Pending
- 2020-03-11 MA MA055319A patent/MA55319A/fr unknown
- 2020-03-11 JP JP2021555270A patent/JP2022526089A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3132975A1 (fr) | 2020-09-17 |
MX2021011031A (es) | 2021-12-10 |
KR20210149727A (ko) | 2021-12-09 |
CN113874502A (zh) | 2021-12-31 |
AU2020239037A1 (en) | 2021-09-30 |
US20220145381A1 (en) | 2022-05-12 |
EP3938507A4 (fr) | 2023-02-22 |
EP3938507A1 (fr) | 2022-01-19 |
JP2022526089A (ja) | 2022-05-23 |
WO2020185811A1 (fr) | 2020-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA55319A (fr) | Procédé de transcription in vitro à alimentation semi-discontinue | |
IL279759A (en) | Bioreactor for in vitro RNA transcription | |
SG11202011539VA (en) | Modified guide rnas for gene editing | |
ZA202007633B (en) | Modified guide rnas | |
IL259005A (en) | Surfaces for redirecting light and manufacturing methods | |
SG11201708681SA (en) | Method for in vitro transcription using an immobilized restriction enzyme | |
EP3294880A4 (fr) | Arn de guidage unique synthétique pour l'édition de gène médiée par cas9 | |
EP3266900A4 (fr) | TÔLE D'ACIER PLAQUÉE D'Al-Zn-Mg-Si EN FUSION ET PROCÉDÉ DE FABRICATION S'Y RAPPORTANT | |
EP3957629C0 (fr) | Procédé de préparation d'hydroxy-benzbromarone deutéré et ses produits intermediaires | |
MA41380A (fr) | Structure en forme de plaque, réservoir et procédé | |
MA52983A (fr) | Procédé de distribution micellaire | |
PT3294903T (pt) | Método para o diagnóstico in vitro da demência com corpos de lewy usando transcritos do gene da alfa-sinucleína | |
GB201806559D0 (en) | Low-pressure upsetting-bulging method for forming hollow member having complex cross-section | |
MA45725A (fr) | Structure en forme de plaque, réservoir et procédé | |
PL3150295T3 (pl) | Maszyna i metoda półciągłego gięcia na zimno sekcji o niskiej ciągliwości | |
EP3450554A4 (fr) | Procédé de criblage in vitro à grande vitesse | |
EP3437789A4 (fr) | Matériau de revêtement en alliage d'aluminium et procédé de production de matériau de revêtement en alliage d'aluminium | |
FR3033479B1 (fr) | Procede de fabrication d'un masque de beaute a support bio-cellulosique et masque associe | |
IL283901A (en) | Process pharmacists and intermediaries | |
GB2556285B (en) | Photomask for optical alignment and optical alignment method | |
PT3469138T (pt) | Método e aparelho para produzir um membro de tração sintético com um comprimento preciso e estabilidade melhorada | |
SI3093613T1 (sl) | Postopek za merjenje in prilagajanje debeline stene cevi | |
EP3768487C0 (fr) | Procédé de micromoulages d'articles | |
GB201805662D0 (en) | Nanostructures and Process For Production | |
EP3389363B8 (fr) | Procédé de floraison in vitro |